Ironwood Pharmaceuti (IRWD) 14.24 $IRWD Aegerion (AEGR):

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ironwood Pharmaceuti (IRWD) 14.24 $IRWD

Aegerion (AEGR): What Awaits for the Stock in Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - 2 hrs 3 mins ago
Aegerion (AEGR) is expected to report second-quarter 2016 results on Aug 3.
IPXL: 31.44 (+0.02), IRWD: 14.24 (+0.11), AEGR: 1.48 (+0.04), EXEL: 9.28 (+0.10)

Keryx (KERX) Q2 Earnings Preview: Will the Stock Gain?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 4:13PM CDT
Keryx Biopharmaceuticals, Inc. (KERX) is expected to report second-quarter 2016 results on Aug 3.
IPXL: 31.44 (+0.02), IRWD: 14.24 (+0.11), KERX: 5.18 (-2.18), EXEL: 9.28 (+0.10)

What's in Store for Prothena (PRTA) This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 3:44PM CDT
Prothena Corporation plc (PRTA) is expected to report second-quarter 2016 results on Aug 2.
IPXL: 31.44 (+0.02), IRWD: 14.24 (+0.11), PRTA: 56.17 (+1.12), EXEL: 9.28 (+0.10)

Whta's in Store for Endocyte (ECYT) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:59AM CDT
Endocyte, Inc. (ECYT) is expected to report second-quarter 2016 results on Aug 2.
IPXL: 31.44 (+0.02), ECYT: 3.23 (+0.05), IRWD: 14.24 (+0.11), EXEL: 9.28 (+0.10)

Mallinckrodt (MNK) Q3 Earnings: Will the Stock Surprise?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:47PM CDT
Mallinckrodt plc (MNK) is set to report third-quarter fiscal 2016 results on Aug 2.
MNK: 67.21 (-0.13), IRWD: 14.24 (+0.11), MDCO: 39.28 (+0.17), EXEL: 9.28 (+0.10)

AmerisourceBergen (ABC) Q3 Earnings: Stock to Surprise?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 11:10AM CDT
AmerisourceBergen Corporation (ABC) is set to report third-quarter fiscal 2016 results on Aug 2, before the opening bell.
ABC: 85.67 (+0.48), WBA: 79.29 (+0.04), IRWD: 14.24 (+0.11), BMY: 75.81 (+1.00)

McKesson (MCK) Q1 Earnings: Stock Likely to Beat?
Zacks Equity Research - Zacks Investment Research - Mon Jul 25, 5:35PM CDT
McKesson Corporation (MCK) is scheduled to report first-quarter fiscal 2017 results on Jul 27, after the market closes.
MCK: 193.62 (-0.94), IRWD: 14.24 (+0.11), BMY: 75.81 (+1.00), EXEL: 9.28 (+0.10)

Herbalife and Ironwood advance; Infosys and Fairmount drop
AP - Fri Jul 15, 3:11PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Friday:
SGYP: 4.13 (+0.05), HLF: 67.45 (-0.56), FMSA: 6.41 (-0.44), IRWD: 14.24 (+0.11), CCL: 46.65 (-0.07), C: 43.71 (-0.10), WFC: 47.76 (-0.21), INFY: 16.51 (+0.08)

First Week of February 2017 Options Trading For Ironwood Pharmaceuticals (IRWD)
DividendChannel.com - Tue Jun 21, 10:00AM CDT
Investors in Ironwood Pharmaceuticals Inc. saw new options begin trading this week, for the February 2017 expiration.
IRWD: 14.24 (+0.11)

Ironwood/Allergan's Linzess sNDA Accepted for FDA Review
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 10:31AM CDT
Ironwood (IRWD) and Allergan's (AGN) sNDA for the 72 mcg dose of Linzess for the treatment of adults with CIC has been accepted for review by the FDA.
AGN: 253.36 (+0.41), IRWD: 14.24 (+0.11), AZN: 33.95 (-0.19), JNP: 7.60 (+0.06)

Technical Analysis on Drugs - Generic Equities -- Akorn, Ironwood Pharma, Catalyst Pharma, and Pacira Pharma
PR Newswire - Fri Jun 10, 7:00AM CDT
On Thursday, June 09, 2016, the NASDAQ Composite ended the trading session at 4,958.62, down 0.32%; the Dow Jones Industrial Average edged 0.11% lower to finish at 17,985.19; and the S&P 500 closed at 2,115.48, down 0.17%. ActiveWallSt.com has initiated coverage on the following equities: Akorn Inc. (NASDAQ: AKRX), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX), and Pacira Pharmaceuticals Inc. (NASDAQ: PCRX). Learn more about these stocks by accessing their free trade alerts at:
IRWD: 14.24 (+0.11), CPRX: 0.74 (+0.02), AKRX: 34.05 (-0.18), PCRX: 37.71 (+1.46)

Ironwood and Allergan Announce Supplemental New Drug Application for 72 mcg Linaclotide in Chronic Idiopathic Constipation Has Been Accepted for FDA Review
PR Newswire - Thu Jun 09, 7:01AM CDT
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for the 72 mcg dose of linaclotide for use in the treatment of adults with chronic idiopathic constipation (CIC). The sNDA for the 72 mcg dose of linaclotide is based on efficacy and safety data from a double-blind, placebo-controlled Phase III clinical trial of 1,223 adult patients with CIC. The FDA Prescription Drug User Fee Act (PDUFA) target action date is expected to occur in early 2017.
AGN: 253.36 (+0.41), IRWD: 14.24 (+0.11)

Ironwood Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference
BusinessWire - Mon Jun 06, 3:01PM CDT
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Jefferies 2016 Healthcare Conference on Friday, June 10, 2016 at 2:30 p.m. Eastern Time in New York City.
IRWD: 14.24 (+0.11)

AstraZeneca Sells Zurampic's EU and Latin American Rights
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 9:19AM CDT
AstraZeneca (AZN) entered into a licensing agreement granting Gr??nenthal the rights to its gout drug Zurampic in the EU and Latin America.
IRWD: 14.24 (+0.11), ANIP: 60.01 (-0.59), AZN: 33.95 (-0.19), BMY: 75.81 (+1.00)

Ironwood Pharmaceuticals Closes U.S. Transaction with AstraZeneca for Lesinurad
BusinessWire - Fri Jun 03, 1:00AM CDT
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that it has closed the previously-announced transaction with AstraZeneca for the exclusive U.S. rights to all products containing lesinurad. Lesinurad 200mg tablets were approved as ZURAMPIC(R) by the U.S. Food and Drug Administration (FDA) in December 2015 for use in combination with a xanthine oxidase inhibitor (XOI) for the treatment of hyperuricemia associated with uncontrolled gout. The licensing agreement includes exclusive U.S. rights to the fixed-dose combination of lesinurad and allopurinol. AstraZeneca plans to submit, on Ironwood's behalf, the fixed-dose combination program for FDA regulatory review in the second half of 2016. The agreement also includes certain rights to potentially access RDEA3170 in gout indications in the U.S.
IRWD: 14.24 (+0.11)

Ironwood Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare Conference
BusinessWire - Wed Jun 01, 3:01PM CDT
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016 at 4:00 p.m. Pacific Time/7:00 p.m. Eastern Time at the Terranea Resort in Rancho Palos Verdes, California.
IRWD: 14.24 (+0.11)

Ironwood Pharmaceuticals to Present at 2016 UBS Global Healthcare Conference
BusinessWire - Wed May 18, 3:01PM CDT
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 2016 UBS Global Healthcare Conference on Wednesday, May 25, 2016 at 9:00 a.m. Eastern Time at the Grand Hyatt New York.
IRWD: 14.24 (+0.11)

Ironwood Pharmaceuticals to Present Linaclotide Data at Digestive Disease Week(R) 2016
BusinessWire - Tue May 17, 7:00AM CDT
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the presentation of linaclotide-related clinical and preclinical data from the company and its collaborators during Digestive Disease Week(R) (DDW) 2016 in San Diego, CA, May 21 through May 24, 2016.
IRWD: 14.24 (+0.11)

Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update
BusinessWire - Mon May 09, 3:05PM CDT
--- LINZESS(R) (linaclotide) U.S. net sales increased ~44% to $137 million in 1Q 2016 compared to 1Q 2015; on track to exceed $1 billion in net sales by 2020 -
IRWD: 14.24 (+0.11)

Drug Stocks' Earnings Previews: FGEN, IRWD, ENTA, FLML
Zacks Equity Research - Zacks Investment Research - Fri May 06, 9:19AM CDT
However, a few companies are still yet to report quarterly numbers. Let's see what we can expect from a few drug stocks reporting earnings early next week.
BIIB: 304.90 (+14.97), ABT: 45.29 (+0.54), JNJ: 125.42 (+0.19), FLML: 12.88 (+0.37), IRWD: 14.24 (+0.11), GILD: 80.89 (+1.42), AMGN: 174.27 (+2.24), FGEN: 19.76 (+0.63), ENTA: 22.50 (+0.01), NVS: 83.18 (-0.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ballard's Q3 2026: Navigating Losses and Bold Moves

Updated Category News Views 29

Ballard’s Financial Puzzles in Q3 2026 Riding the rough waters of the third quarter in 2026, Ballard Power Systems set out its stall with some eyebrow-raising numbers. This ain't the bustling diner vibe we normally see for a thriving business. The results paint a cautious picture sprinkled with strategic shifts that demand a keen eye. GeoPura Acquisition: A Strategic...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 97

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 181

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 385

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 74

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 41

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 112

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 67

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 635

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
AI Pushes Asset Managers Towards New Investment Growth

Updated Category News Views 5

AI: A Double-Edged Sword for Asset Managers Peeled straight from the heart of New York's financial buzz, AI is changing the game for asset and wealth managers. Now, we ain’t talking about some futuristic sci-fi scene, but real-world shifts that are scratching their way into boardrooms. Nearly 80% of firms playing the AI card see a sweet lift in productivity and...

Continue Reading

Top 5 Most Recently Viewed Articles

Movable Ink Boosts AI Marketing Strategies with Global Expansion

Updated Category News Views 165

Movable Ink Expands its AI Marketing Solutions Across Europe Movable Ink, a leader in AI-powered personalisation, has significantly boosted its presence in Europe. The company’s innovative approach, termed the Autonomous Marketing strategy, is proving to reshape the marketing landscape. Now, with the launch of its sophisticated Da Vinci product, Movable Ink is setting a...

Continue Reading
Crypto Market Update: Election Impact on Bitcoin and Ethereum

Updated Category News Views 110

Market Movements Amid Election Uncertainty In recent days, leading cryptocurrencies have experienced a noticeable pullback. The shifts in market sentiment appear closely linked to the political atmosphere, particularly surrounding presidential election predictions. As the likelihood of Donald Trump's election victory declined, key cryptocurrencies like Bitcoin and...

Continue Reading
Festi hf. Receives Non-Binding Offers for Olíudreifing ehf.

Updated Category News Views 101

Festi hf. Receives Non-Binding Offers for Olíudreifing ehf. Festi hf. has recently announced the progress concerning Olíudreifing ehf. which is a crucial infrastructure entity specializing in fuel storage and distribution in Iceland. After initiating the sales process on September 26, 2024, the company has now received non-binding offers for all outstanding shares in...

Continue Reading
Canadian Solar Plans US$200 Million Convertible Notes Offering

Updated Category News Views 141

Canadian Solar Announces Offering of Convertible Senior Notes Canadian Solar Inc. (NASDAQ: CSIQ) has recently disclosed plans for the proposed offering of US$200 million in convertible senior notes due 2031. This offering is contingent upon market conditions and other factors. The convertible notes are set to be offered and sold privately to qualified institutional...

Continue Reading
HPQ Silicon Achieves Milestone with First Battery Cell Shipments

Updated Category News Views 185

HPQ Silicon's Exciting Development in Battery Technology HPQ Silicon Inc. (“HPQ”) is thrilled to announce that it has successfully completed and shipped its first industrial batches of high-performance lithium-ion battery cells. Manufactured using their innovative GEN3 silicon-based anode material, these initial cells, which come in the 18650 and 21700 formats under...

Continue Reading